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Abstract 20 
 21 
Giving birth is a critical time for many species and is often the most painful event ever 22 
experienced by females. In domestic species, like the pig, pain associated with parturition 23 
represents a potential welfare concern, and the consequences of pain can cause economic 24 
losses (e.g. by indirectly contributing to piglet mortality as pain could slow post-farrowing 25 
recovery, reduce food and water intake, reducing milk let-down). This study investigated pain 26 
assessment and its management in primiparous (gilts) and multiparous (sows) breeding pigs, 27 
including the provision of a non-steroidal anti-inflammatory drug (NSAID) post-parturition. 28 
Individuals were randomly allocated to receive the NSAID ketoprofen (3mg/kg bodyweight) 29 
(n = 11 gilts, 16 sows) or the equivalent volume of saline (n = 13 gilts, 16 sows) by 30 
intramuscular injection 1.5 hours after the birth of the last piglet. Data collected included 31 
putative behavioral indicators of pain (back leg forward, tremble, back arch), salivary cortisol 32 
concentrations pre-farrowing and up to 7 days post-injection. In addition, post-partum 33 
biomarkers of inflammation, including the acute phase protein C-reactive protein (CRP) and 34 
3 porcine cytokines (interleukin-1 β (IL1 β), interleukin-6 (IL6) and tumor necrosis factor α 35 
(TNF α)) were measured in plasma collected 6 hours following the injection. Behaviors were 36 
analyzed using generalized linear mixed models, and physiological variables with linear 37 
mixed models. No difference in putative pain behaviors, salivary cortisol, CRP or cytokines 38 
were found between individuals treated with ketoprofen or those administered the saline 39 
control. However, there were some differences between gilts and sows, as sows exhibited 40 
more putative pain behavior than gilts, had higher salivary cortisol on the day of farrowing 41 
and had higher plasma TNF α. Conversely, gilts had higher salivary cortisol than sows on day 42 
3 post farrowing and had higher CRP. This indicates that, like human females, multiparous 43 
sows experience more pain from uterine activity following birth than primiparas. This study 44 
provides useful information for developing management practices relating to post-farrowing 45 
care for breeding pigs. 46 
 47 
Keywords: behavior, parturition stress, physiology, pain assessment, sow, welfare 48 
 49 
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1. Introduction 50 
 51 
For human females, giving birth is often the most painful event ever experienced, 52 
with a high percentage of women reporting severe or extremely severe pain (Melzack, 1984). 53 
It is now widely accepted that many animals are capable of experiencing pain (Sneddon et al., 54 
2014) and pain associated with parturition in domestic pigs has been discussed in a recent 55 
review (Mainau and Manteca, 2011). 56 
  57 
Farrowing is a critical time in pig production, as success at this stage of the system 58 
means more piglets are weaned and ultimately sold. The breeding sow is essential for 59 
successful production around farrowing, and good health and welfare of the sow is reflected 60 
in her ability to produce a healthy litter of piglets. Any farrowing difficulties or reduced milk 61 
production can result in higher pre-weaning piglet losses (Peltoniemi and Oliviero, 2015). 62 
Parturition is likely to be painful in the pig as it is in other species as pain is likely to 63 
originate from uterine contractions, piglet expulsion and inflammation of the uterine tract 64 
from delivering a litter of piglets (Mainau and Manteca, 2011). After birth, pain in human 65 
females can be present from intermittent uterine contractions during the process of 66 
involution, when the uterus returns to its normal size and from tissue damage associated with 67 
a natural birth (Deussen et al., 2011). Post-birth pain experienced by the mother has 68 
implications for her ability to recover in order to return normal activities and feed and care 69 
for her baby (Deussen et al., 2011). It has been suggested that pain experienced by the sow 70 
post-farrowing, could affect her ability to feed and care for piglets (Mainau and Manteca, 71 
2011; Peltoniemi and Oliviero, 2015), which is a welfare concern for the sow and piglets and 72 
also an economic one for the farmer. This has resulted in recent research administering non-73 
steroidal anti-inflammatory drugs (NSAIDs) post-farrowing and measuring the benefits to 74 
health, welfare and productivity (Homedes et al., 2014; Mainau et al., 2012; Sabaté et al., 75 
2012; Tenbergen et al., 2014; Viitasaari et al., 2013, 2014).  76 
 77 
Benefits of the post-farrowing administration of NSAIDs include a reduction in piglet 78 
mortality with the use of ketoprofen (Homedes et al., 2014; Sabaté et al., 2012), and an 79 
increased average daily weight gain of low birth weight piglets (< 1180 g) with the use of 80 
intramuscular meloxicam (Mainau et al., 2012). A study in which oral meloxicam was 81 
administered as soon as possible after the onset of farrowing showed improved piglet 82 
weaning weight, average daily gain and evidence for improved immunoglobulin-G (IgG) 83 
transfer (Mainau et al., 2016). Sows treated with intramuscular meloxicam spent less time 84 
lying on the third day following parturition (Mainau et al., 2012) and younger sows treated 85 
with ketoprofen were more active than those given a placebo (Viitasaari et al., 2014), which 86 
may indicate improved recovery post-farrowing. Other sow health and welfare benefits of 87 
ketoprofen included a reduced loss in back-fat and body condition score, a lower incidence of 88 
constipation and less severe shoulder sores (Viitasaari et al., 2013). The administration of 89 
NSAIDs, in addition to antibiotics, has also been shown to aid in treatment of infectious 90 
causes of post-partum dysgalactia syndrome (PPDS) (e.g. (Hirsch et al., 2003; Tummaruk 91 
and Sang-Gassanee, 2013)) and, on farms with a high incidence of subclinical forms of the 92 
condition, piglet mortality was reduced (Sabaté et al., 2012). 93 
 94 
Ketoprofen is an NSAID with anti-inflammatory, analgesia and antipyretic properties, 95 
with a number of brands available and licensed to treat conditions involving pain, 96 
inflammation and fever in pigs in the UK (VMD, 2011). It is absorbed well, reaching 97 
maximum levels after approximately 1 hour following intra-muscular (IM) injection 98 
(Raekallio et al., 2008). Nociceptive thresholds were reduced in piglets with kaolin-induced 99 
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inflammation, when administered ketoprofen compared with a placebo up to 24 hours 100 
following IM injection (Fosse et al., 2011). It is the second most popular NSAID in the UK, 101 
after meloxicam; reported to be used or prescribed by 50% of pig veterinarians (Ison and 102 
Rutherford, 2014). Ketoprofen is licensed for use in pigs in the UK to be used along with 103 
antimicrobials to treat respiratory disease, mastitis and metritis (or PPDS) at a dose rate of 3 104 
mg per kg bodyweight (VMD, 2011). Scientific research has demonstrated the efficacy of 105 
ketoprofen in experimentally infected pigs (Mustonen et al., 2012; Swinkels et al., 1994), to 106 
treat respiratory disease (Salichs et al., 2013) and non-infectious lameness (Mustonen et al., 107 
2011). As previously mentioned, the post-farrowing administration of ketoprofen has shown 108 
health, welfare and production benefits (Homedes et al., 2014; Viitasaari et al., 2013, 2014), 109 
especially on farms with a high incidence of PPDS (Sabaté et al., 2012).  110 
 111 
This study investigated the assessment and management of pain in primiparous 112 
(hereafter referred to as gilts) and multiparous (hereafter referred to as sows) breeding pigs, 113 
including the administration of the NSAID ketoprofen after farrowing. A previous 114 
publication, as part of the same study, presented the effect of post-farrowing ketoprofen on 115 
gilt and sow feed intake, nursing behavior and piglet performance (Ison et al., 2017). This 116 
article focuses on behavioral and physiological measurements taken from gilts and sows as 117 
indicators of stress and pain, including putative behavioral indicators of pain identified 118 
previously (Ison et al., 2016b). Putative behavioral indicators of pain were also measured in 119 
the hours preceding farrowing, to investigate the onset of potentially painful uterine 120 
contractions as farrowing approached.  121 
 122 
2. Materials and Methods 123 
 124 
This experiment was carried out under UK Home Office License, in compliance with 125 
EU Directive 2010/63/EU, and following approval from the SRUC Animal Welfare and 126 
Ethical Review Body (AWERB). 127 
 128 
2.1. Gilt and sow housing and husbandry 129 
 130 
Thirty-two Large White × Landrace multiparous (sows; mean parity 4.63 ± 0.43 131 
(SEM)) and 24 primiparous (gilts) breeding pigs were used in this study. The gilts in this 132 
study were acquired directly from a breeding company (The Camborough®, PIC, UK), 133 
whereas the sows were home bred from an older genetic line of the same breed. Experimental 134 
procedures were carried out at the SRUC pig research farm (Midlothian, UK), with gilts and 135 
sows farrowing in 9 batches between February and October 2014. Approximately 4 days 136 
before the expected farrowing date, gilts and sows were moved into individual conventional 137 
farrowing crates (1.8 × 0.5 m), with solid concrete flooring (1.8 × 1.5 m), a small slatted area 138 
at the back (0.5 × 0.5 m) and a water and feed trough at the front. A heated creep area (1.5 × 139 
0.65 m) was accessible to piglets, positioned in front of the water and feed trough. Individuals 140 
were fed a standard pelleted lactation diet (16.4% crude protein, 6.8 % crude oils and fats, 141 
4.0% crude fiber, 5.8% crude ash, 13.8% moisture, 0.8% calcium, 0.94% lysine, 0.25% 142 
methionine, 0.51% phosphorus and 0.22% sodium) twice a day at 0745 and 1530 and had 143 
continuous access to fresh water. Gilts and sows were fed based on a feed chart, which was 144 
adjusted slightly according to the size, body condition and appetite of the individual (e.g. gilts 145 
were fed slightly less than sows and a lower body condition score was given slightly more 146 
feed) and increased gradually from the day of farrowing to weaning. Gilts and sows were 147 
cleaned out daily at the morning feed, when they were provided with 2 handfuls of fresh, 148 
long-stemmed straw. Additional straw was added and any manure removed at the afternoon 149 
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feed in the days preceding farrowing, to provide adequate nest-building material and maintain 150 
hygiene for the newborn piglets. Lights were switched on immediately before the morning 151 
feed, turned off at 1630 and an additional night-light was provided in the center of each room 152 
of crates.  153 
 154 
Cross-fostering was conducted where necessary to even up litter sizes, in order to 155 
maximize piglet survival as per normal farm practice. Cross fostering was conducted 156 
independently of experimental treatments and was conducted only after the 6 hour post-157 
injection data collection point. When litter sizes were uneven, the largest piglet or piglets 158 
were removed and placed on a gilt or sow with a smaller litter. Piglets were given an 159 
intramuscular injection of iron on day 3 post-farrowing, as per normal farm practice. On the 160 
4
th
 week after farrowing (mean piglet age 26.39 ± 0.20 (SEM)), weaning took place, which 161 
involved moving gilts and sows out of the crates, followed by ear tagging and vaccination 162 
(CircoFLEX) of the piglets, which is normal farm practice. 163 
 164 
2.2. Blinding and drug treatments 165 
 166 
This study was a randomized, blinded, placebo controlled trial, where gilts and sows 167 
were randomly allocated to receive a single intra-muscular (IM) injection of ketoprofen 168 
(Ketofen; Merial Animal Health Limited, Harlow, Essex, UK) or the equivalent volume of 169 
saline, 90 minutes following the birth of the last piglet. Ketoprofen-treated gilts and sows 170 
received 3 mg per kg bodyweight or 1 ml per 33 kg bodyweight rounded down to the nearest 171 
0.5 ml (treated), and those that received the saline as a placebo control were given the 172 
equivalent volume (control). The 56 individuals were balanced as much as possible across the 173 
different batches and for parity between the 2 treatment groups (gilts: treated, n = 11, control, 174 
n = 13; sows: parity 2 to 4; treated, n = 9, control, n = 8; parity 5 to 7; treated, n = 5, control, 175 
n = 6; parity 8+; treated, n = 2, control, n = 2). After the first experimenter had allocated 176 
individuals to the 2 treatments groups, a second experimenter added the ketoprofen or saline 177 
dose to individual brown medicine bottles, sealed with rubber stoppers (Adelphi Healthcare 178 
Packaging, Haywards Heath, West Sussex, UK), which were labelled only with the individual 179 
gilt or sow ear tag identification number. Ketofen contains the active ingredient ketoprofen at 180 
100 mg/ml contained in a solution of l arginine, benzyl alcohol (10 mg/ml), citric acid 181 
monohydrate, and water. It is a clear colorless solution, with low viscosity, making it 182 
indistinguishable from the saline placebo to the third experimenter who administered the 183 
injection, and collected the data, who was blind to the treatments.  184 
 185 
In the days leading up to farrowing, individuals were closely monitored for signs of 186 
farrowing, which included observation at twice daily feeding, and through remote monitoring 187 
using a digital surveillance system. Once the piglet expulsion phase began, the time of each 188 
piglet birth was recorded and when a 90 minute gap from the last piglet birth and the gilt or 189 
sow appeared to have finished farrowing, the ketoprofen or saline treatment was 190 
administered. Ketoprofen was injected into the neck muscle, just behind the ear using an 18 191 
gauge, 1.5 inch needle attached to a PVC extension tube and using a 10 or 20 ml syringe 192 
(Henry Schein Animal Health, Dumfries, Dumfries and Galloway, UK). Individuals were 193 
then left undisturbed for 6 hours, before sampling took place (see below). In case of any 194 
adverse effects of the drug being administered, and if any additional treatments were needed 195 
within 24 hours (e.g. if gilts/sows showed signs of PPDS), the farm manager was given a list 196 
of the pig ear tags and treatments and was responsible for any additional treatments that were 197 
required, to avoid double dosing with NSAIDs.   198 
  199 
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2.3. Gilt and sow behavior 200 
  201 
Closed-circuit television (CCTV) cameras (LL20, infra-red cameras, FR concepts, 202 
Ireland) were mounted above each farrowing crate, and were connected to a computer to 203 
record behavior using GeoVision Digital Surveillance System software (ezCCTV ltd, Herts, 204 
UK). This surveillance system enabled remote monitoring. Digital video footage was 205 
collected and stored to be observed later using The Observer XT 11.0 (Noldus Information 206 
Technology, Wageningen, The Netherlands). Continuous behavioral observations were made 207 
for 5 minutes every hour for 24 hours before the first piglet birth. Behavior recorded included 208 
gilt and sow posture and a set of other spontaneous putative pain behaviors described in 209 
Table 1. After farrowing, individuals were observed for 15 minutes every 1.5 hours, starting 1 210 
hour after the last piglet was born for a total of 8 observations. After these 8 observations, 3 211 
more 15 minute observations were made at 3 hour intervals. Therefore, the first 15 minute 212 
observation was 0.5 hours before the injection (Pre -0.5) and the remaining observations 213 
afterwards (Post 1.0, 2.5, 4.0, 5.5, 7.0, 8.5, 10.0, 13.0, 16.0, 19.0). Posture and putative pain 214 
behaviors were also observed during these post-farrowing observations (Table 1).  215 
 216 
2.4. Gilt and sow physiology 217 
 218 
2.4.1. Salivary cortisol 219 
 220 
Gilts and sows were saliva sampled after the morning (between 0845 and 0915) and 221 
afternoon (between 1545 and 1615) feed pre-farrowing, on the day of farrowing, including an 222 
additional sample 6 hours after the injection, then up to 7 days after farrowing. Individuals 223 
were offered 2 large cotton buds (Millpledge Veterinary, Clarborough, Nottinghamshire, UK) 224 
on which to chew for approximately 30 seconds or until saturated with saliva. The cotton 225 
buds were placed into pre-labelled Salivette tubes (SARSTEDT AG & Co., Nümbrecht, 226 
Germany), which were sealed and centrifuged for 5 minutes at 1400 g. The supernatant was 227 
pipetted into pre-labelled 1.5 ml tubes and stored at -20
o
C for assay at a later date. For each 228 
gilt and sow, samples from 2 days pre-farrowing, the day of farrowing, and days 1, 2, 3, 5, 229 
and 7 post farrowing were assayed. 230 
 231 
On the day of assay, saliva samples were removed from the freezer to thaw. All 232 
samples were centrifuged at 2300 g for 5 minutes and the supernatant pipetted into a clean, 233 
pre-labelled 1.5 ml tube to remove any particulate matter in the sample. Using Coat-A-Count 234 
cortisol radioimmunoassay kits (Siemens Healthcare Diagnostics Ltd., Camberley, UK), 200 235 
μl of standards, quality controls (QCs), and undiluted unknown saliva samples were pipetted 236 
in duplicate into the antibody coated assay tubes, followed by 1 ml of 
125
I tracer. A standard 237 
curve was placed at the beginning and end of the assay, followed by 3 QCs (low, medium and 238 
high) and another set of QCs were added to the middle of the assay. Assay tubes were stored 239 
at 4 
o
C overnight for incubation. On the following day, the tubes were emptied (apart from 240 
the total count tubes), counted with a gamma counter (LKB-Wallac 1261), and concentrations 241 
calculated using AssayZap software (Biosoft, Cambridge, UK). Salivary cortisol 242 
concentrations were reported as nanograms per milliliter (ng/ml) and the range of the assay 243 
was 0.125 to 50 ng/ml. 244 
 245 
The lower and upper detectable limits for the salivary cortisol assays were 0.434 and 246 
54.423 ng/ml respectively. The average intra-assay coefficient of variation (CV) across 7 247 
assay runs was 5.92% (7.06%, 6.67%, 5.79%, 4.96%, 6.07%, 5.43% and 5.44% for assay 248 
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runs 1 to 7 respectively). The inter-assay CV, based on sets of 3 (low, medium and high) 249 
samples per assay run of known cortisol concentration was 10.56%.  250 
 251 
2.4.2. C-reactive protein (CRP) and cytokines (IL1 β, IL6, and TNF α) 252 
 253 
At 7.5 hours after the injection, a blood sample was collected from the dams. Due to a 254 
previous study, showing greater putative pain behavior in the first 6 hours after the last piglet 255 
birth (Ison et al., 2016b), all individuals were left as undisturbed as possible during this time. 256 
Therefore, at 6 hours after the treatment/control injection, each gilt or sow had her tail and ear 257 
cleaned with antiseptic wipes. A topical local anesthetic cream (EMLA®) was then applied to 258 
the tail and ear, and cling film was placed around the tail over the cream and held in place 259 
with micro-pore tape, to form an occlusive dressing. To allow the anesthetic cream to take 260 
effect, all other samples and measurements were taken, and blood sampling took place 261 
approximately 1.5 hours after the cream was applied. The tail vein was first attempted and if 262 
unsuccessful, the ear vein was used; it was possible to sample from the tail for 17 gilts and 27 263 
sows and the ear vein was used for the remaining 7 gilts and 5 sows (gilts were tail docked, 264 
sows had intact tails). Firstly the tail vein was attempted, by holding the tail up, away from 265 
the body, feeling for the last moveable tail joint. At this point, on the midline of the tail, a 20 266 
gauge, 1 inch vacutainer needle, attached to a vacutainer needle holder (Henry Schein Animal 267 
Health, Dumfries, Dumfries and Galloway, UK) was inserted at approximately a 45
o
 angle. A 268 
6 ml EDTA vacutainer (Henry Schein Animal Health, Dumfries, Dumfries and Galloway, 269 
UK) was pushed towards the needle to fill with blood and if the vein was not found, the 270 
needle was gently moved around until it was. If the tail vein was not successful after 3 271 
attempts, the ear vein was used. Polypropylene tubing was wrapped around the ear and held 272 
in place using locking forceps, to allow the ear veins to become prominent. Once raised, a 21 273 
gauge 0.75 inch winged vacutainer needle (Henry Schein Animal Health, Dumfries, Dumfries 274 
and Galloway, UK) attached to a vacutainer needle holder was inserted into the most 275 
prominent raised vein. The forceps were then removed and a 6 ml EDTA vacutainer was 276 
pushed onto the needle to collect blood, again, if blood was not drawn, the needle was gently 277 
moved until blood appeared in the vacutainer. Blood was immediately placed on ice, then 278 
moved straight into a refrigerated centrifuge (at 4 
o
C) and centrifuged for 15 minutes at 1400 279 
g. Plasma was pipetted into 4 1.5 ml pre-labelled tubes and frozen at -80 
o
C to be assayed at a 280 
later date. 281 
 282 
Plasma samples were assayed for C-reactive protein (CRP) using a commercially 283 
available ELISA kit (Alpco ®, Salem, New Hampshire, USA), extensively used previously to 284 
measure levels of CRP in studies of pigs (e.g. (Che et al., 2011)). Samples were removed 285 
from the -80
o
C freezer the evening before the assay and placed at 4
o
C overnight to gradually 286 
defrost. On the day of the assay, samples were placed at room temperature for 30 minutes and 287 
were centrifuged for 1 minute at 865 g before any further preparation took place. An initial 288 
test plate was run to establish the best dilution for the samples, with a 1:5000 dilution chosen. 289 
Dilution buffer was prepared according to the instructions and samples were diluted using 290 
plain 96-well V-bottomed plates. A plate layout was created with standards, blanks and 291 
samples. According to the kit instructions, the CRP calibrator was reconstituted and the 6 292 
standards created using a 2-fold serial dilution. Assay buffer was used for a zero standard and 293 
blanks. According to the plate layout, 130 μl of standards, samples and blanks were then 294 
pipetted into a plain V-bottomed plate, before 100 μl was pipetted into the antibody coated 295 
plate supplied with the kit. The assay was then conducted according to the manufacturer’s 296 
instructions. Samples were assayed across 2 plates, with treatments and gilts and sows 297 
balanced across plates as much as possible and 3 samples and a reference serum that came 298 
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with the kit, were run on both plates to act as quality controls (QCs) to calculate inter-plate 299 
variation. The plate was read using a Multiskan
TM
 FC Microplate Photometer plate reader and 300 
results calculated using a 5 point logistic regression curve using Thermo Scientific SkanIt
TM
 301 
for Multiskan
TM
 FC software (version 2.5.1) (Thermo Fisher Scientific Inc, Waltham, 302 
Massachusetts, USA). The assay range was 6.25 to 200 ng/ml and sample results with a CV% 303 
of greater than 10% were repeated. 304 
 305 
Also using the gilt and sow plasma, simultaneous quantification of 3 porcine 306 
cytokines (interleukin-1 β (IL1 β), interleukin-6 (IL6) and tumor necrosis factor α (TNF α)) 307 
in a single plasma sample was conducted using multiplex fluorescent microsphere 308 
immunoassays (FMIA) with the BioPlex® 200 system (Bio-Rad Laboratories Ltd., Hemel 309 
Hempstead, UK). Details of the development, including optimization of this multiplex assay 310 
for porcine samples is currently in press (Hall and Zanella) and further details for running the 311 
assay have also been published previously (Hall et al., 2015). Briefly, capture antibodies for 312 
each cytokine were coupled to microspheres (beads) using the Bio-Plex amine coupling kit 313 
following the manufacturer’s instructions (Bio-Rad Laboratories Ltd., Hemel Hempstead, 314 
UK). Samples were removed from the -80 
o
C freezer on the morning of the assay and put on 315 
ice before further processing. Samples were undiluted for the assay. Standards were created 316 
using a 2.5 fold serial dilution to create 7 standards from 10,000 to 40.96 pg/ml for each 317 
cytokine, Table 2 (adapted from Hall and Zanella) shows the source of the recombinant 318 
protein for the standards and the capture and detection antibodies. To run the FMIA, firstly a 319 
mastermix solution of at least 3600 beads per region (cytokine) per well was produced, then 320 
50 μl was added to each well of a black flat bottomed 96-well plate (BioRad catalogue 321 
#171025001). The plate was then washed twice with phosphate buffered saline (PBS) using a 322 
Bio-Plex Pro II wash station (Bio-Rad Laboratories Ltd., Hemel Hempstead, UK), with the 323 
magnetic plate washing carrier installed. Then, 50 μl of standards, unknown samples and 324 
blanks were added to the plate, which was incubated in the dark for 1.5 hours at room 325 
temperature, with shaking at 700 rpm. Following this, the plate was washed 3 times (as 326 
before) and 75 μl of detection antibody was added and the plate was incubated for 40 minutes 327 
as before. After another 3 washes, 50 μl of Streptavidin-PE solution (Bio-Rad Laboratories 328 
Ltd., Hemel Hempstead, UK) was added and the plate was incubated for a further 20 minutes. 329 
The plate was then washed 3 times, 125 μl of assay buffer was added and the plate was 330 
incubated with shaking for 5 minutes. The reaction was measured using the BioPlex® 200 331 
instrument and analyzed using the Bio-Plex manager software (version 6.1), using a 5 point 332 
logistic regression to calculate a standard curve for each cytokine. For each well, mean 333 
fluorescent intensity was analyzed for 100 beads for each cytokine. Samples were run across 334 
3 plates and CV% of greater than 20% for any of the cytokines were repeated and if the CV 335 
failed to fall below 20%, the result was treated as a missing value. 336 
 337 
The lower and upper detectable differences for the cytokine multiplex assay was 4.61 338 
and 817.54 pg/ml for IL1 β, 0.23 and 1461.22 pg/ml for IL6, and 0.42 and 162.02 pg/ml for 339 
TNF α. The intra-assay CV% for IL1 β, IL6 and TNF α was 0.89%, 2.89% and 6.13% 340 
respectively and the inter-assay CV% was 6.40%, 5.25% and 6.42% for IL1 β, IL6 and TNF 341 
α respectively. For C-reactive protein, the intra-assay CV% was 1.77%. 342 
 343 
2.5. Data analysis 344 
 345 
Unless stated at the start of each results section, data were available for all 346 
individuals. There were 11 gilts and 16 sows in the ketoprofen treated group (treated) and 13 347 
gilts and 16 sows in the saline control group (control). An additional factor in this study was 348 
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that 13 individuals, 5 gilts (4 treated and 1 control) and 8 sows (4 treated and 4 controls) 349 
required additional treatment in the days after farrowing for PPDS. Therefore, data were 350 
analyzed by treatment (treatment vs. control), parity group at the level of gilt vs. sow and 351 
whether additional treatment was needed (yes vs. no). All data were analyzed and descriptive 352 
statistics calculated using R version 3.3.3 (R core team, 2013). Data manipulation and 353 
summaries were conducted using the ‘dplyr’ package and plotted using the ‘ggplot2’ 354 
package. Results were considered statistically significant at P < 0.05 and tendencies will be 355 
discussed at P < 0.1. 356 
 357 
 Behavioral variables, including pre-farrowing and post-injection behaviors (Table 1) 358 
were analyzed using generalized linear mixed modeling, with the glmmPQL function in the 359 
‘MASS’ package. All models included farrowing batch and dam ID as random variables. Pre-360 
farrowing behavior models included gilt or sow and time and their interactions as fixed 361 
factors. Post-injection behavior models included time, gilt or sow, additional treatment (yes 362 
or no), and treatment (treated or control) and their interactions as fixed factors. All models 363 
analyzing count data used the negative binomial family, and for duration variables, a two-step 364 
hurdle model was used (Min and Agresti, 2005). This was conducted by first analyzing the 365 
variables as a binomial outcome (if the behavior occurred or not: 1,0), then for the instances 366 
where the behavior did occur, the durations were analyzed with a gamma distribution and log 367 
link function.  368 
 369 
Physiological variables were analyzed with linear mixed models, using the lmer 370 
function in the ‘lme4’ package, with gilt/sow, treatment, additional treatment and their 371 
interactions as fixed factors. Cytokines and CRP were analyzed with batch, and salivary 372 
cortisol with batch and dam ID in the random model. The salivary cortisol concentrations 373 
were log transformed to improve the model fit, and also included sampling time as a fixed 374 
factor, and post-hoc comparisons between fixed factors with day were made using the 375 
lsmeans function in the ‘lsmeans’ package. 376 
 377 
3. Results 378 
 379 
3.1. Pre-farrowing behavior 380 
 381 
Pre-farrowing behavior was observed for 55 of the 56 individuals; data were missing 382 
for 1 sow in the control treatment group. Tremble and tail flick were not analyzed pre-383 
farrowing as these behaviours were rare. Figure 1 shows gilt and sow postures (A), and 384 
putative pain indicators (B) by hour pre-farrowing. All behaviors apart from sit differed by 385 
hour pre-farrowing (Table 3). Lying lateral decreased from 12 hours pre-farrowing, whilst all 386 
other postures and the frequency of posture changes increased. In the last few hours before 387 
the onset of farrowing, lying lateral increased again, while other postures decreased, but the 388 
frequency of posture changes remained high, indicating restlessness (Figure 1 A). In line with 389 
this restlessness, all putative pain behaviors followed a similar pattern: increasing in the last 390 
few hours before the first piglet birth (Figure 1 B). Table 3 also contains the pre-farrowing 391 
behaviors observed by parity group (gilt or sow), along with the gilt vs. sow and gilt/sow × 392 
hour pre-farrowing interactions. Lie lateral, back arch and the frequency of posture changes 393 
differed overall between gilts and sows (Table 3), with greater lateral lying and more back 394 
arches observed in sows compared with gilts, and more posture changes in gilts than sows. 395 
There was a different pattern of lying lateral, back arch and posture changes between gilts 396 
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and sows across the 24 hours pre-farrowing, with significant gilt/sow × time pre-farrowing 397 
interactions (Table 3). 398 
 399 
3.2. Post injection behavior 400 
 401 
Post injection behavior was observed for 54 of the 56 individuals; data were excluded 402 
for animals (1 control sow and 1 treated sow) who had more piglets after the injection was 403 
given. Figure 2 shows the frequency or duration of putative pain behaviors, and the frequency 404 
of posture changes observed by hour post injection. As shown, back arch, tremble and back 405 
leg forward were lowest 7 hours after the injection, as posture changes were highest, which 406 
coincided with the physiological data collection and piglet processing. Posture changes, paw 407 
and tail flick were not analyzed post injection as these behaviors were infrequent. Back arch 408 
(t = -2.9, P = 0.004) differed by time, decreasing by hour post-injection, whereas back leg 409 
forward (t = 1.7, P = 0.09) and tremble (t = -0.7, P = 0.5) did not differ. Back leg forward, 410 
back arch and tremble did not differ by treatment, additional treatment or their interactions 411 
with time (Table 4). However, back leg forward and back arching differed between gilts and 412 
sows, along with significant gilt/sow × time interactions (Table 4; Figure 3). Gilts exhibited 413 
fewer back arches and less back leg forward behavior than sows, who began with high 414 
values, decreasing with hour post-injection, whereas gilts remained more stable across the 415 
observations.    416 
 417 
3.3. Gilt and sow physiology 418 
 419 
3.3.1. Salivary cortisol 420 
 421 
One sow was not saliva sampled due to aggression towards the sampler, so data 422 
presented are for 24 gilts and 31 sows. Salivary cortisol concentrations differed by day, with 423 
the lowest levels detected 2 days before farrowing (-2), rising significantly on day -1 and 424 
even more on the day of farrowing (Figure 4 A). Cortisol levels remained high up to day 7 425 
post farrowing, with the highest levels measured on day 3 post farrowing. Cortisol did not 426 
differ overall by treatment (t = 0.8, P = 0.4) or between control and treated individuals on any 427 
sampling day (Figure 4 B). Gilts and sows did not differ overall (t = 1.6, P = 0.1), but 428 
differed in salivary cortisol on day 0 (t = -2.3, P = 0.02) with higher concentrations for sows 429 
than gilts, and on day 3 with higher concentrations for gilts than sows (t = 2.4, P = 0.02; 430 
Figure 4 C). Individual requiring additional treatment or not post-farrowing due to PPDS did 431 
not differ overall (t = -0.3, P = 0.8) by those that did not, but those requiring treatment 432 
showed significantly higher cortisol on days 1 (t = -3.0, P = 0.003) and 2 (t = -2.5, P = 0.01) 433 
post-farrowing (Figure 3 D).   434 
 435 
3.3.2. C-reactive protein (CRP) and cytokines (IL1 β, IL6, and TNF α) 436 
 437 
Due to a CV% of greater than 20% data are missing for interleukin-1 β (IL1 β) for 6 438 
individuals, interleukin-6 (IL6) for 9 individuals and tumor necrosis factor α (TNF α) for 11 439 
individuals. There were no significant differences for treatment, or by additional treatment for 440 
any of the cytokines or CRP (Table 5), however, TNF α was higher in sows than gilts (t = 441 
2.2, P = 0.04), and CRP higher in gilts than sows (t = -4.5, P < 0.001). 442 
 443 
4. Discussion 444 
 445 
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Non-steroidal anti-inflammatory drugs reduce pain and inflammation by reducing 446 
prostaglandin synthesis through the inhibition of cyclo-oxygenase (COX) enzymes that 447 
increase following cell damage (Hudson et al., 2008). Prostaglandins, however, are involved 448 
in the process of parturition, as well as inflammation, and prostaglandins have been shown to 449 
increase towards the onset of parturition in pigs, peaking at the time of birth (Gilbert, 2001). 450 
Due to the inhibition of prostaglandins, NSAIDs have been used in human medicine to delay 451 
parturition in cases of preterm birth (Olson, 2005). However, as these drugs cross the 452 
placenta, NSAID use can result in detrimental side effects for the fetus, where prostaglandins 453 
play an important role in developmental and physiological regulation (Bloor and Paech, 454 
2013). This has led to concern over using these drugs in livestock during parturition or 455 
immediately after fetal delivery when placental tissue is being passed. However, in the 456 
current study, there were no apparent adverse effects following, to the piglets or dams, of the 457 
administration of ketoprofen 1.5 hours after the last piglet was born. Two sows had more 458 
piglets after the injection was given, 1 in the ketoprofen and 1 in the control group. In a 459 
previous study in cattle, where the NSAID ketoprofen was administered immediately 460 
following calving, treated dams tended to be less likely to retain fetal membranes than 461 
untreated controls (Richards et al., 2009), and a recent study administering oral meloxicam at 462 
the onset of farrowing reported  no adverse effects and enhanced benefits (Mainau et al., 463 
2016). Therefore, it could be beneficial to administer an NSAID earlier, without detrimental 464 
side effects and additional benefits include the provision of a therapeutic dose to piglets via 465 
the sow’s milk to treat pain and inflammation from routine management procedures in piglets 466 
(Bates et al., 2014).  467 
 468 
4.1. Behavior 469 
 470 
Pre-farrowing behavioral observations of gilts and sows showed an increase in 471 
activity, including a reduction in lying lateral, and an increase in other postures and posture 472 
changes, indicative of nest building behavior (Algers and Uvnäs-Moberg, 2007). Similar to 473 
previous studies, this change in activity, as shown by a reduction in lateral lying, was 474 
apparent from 12 hours before the onset of farrowing (e.g. (Castrén et al., 1993; Jarvis et al., 475 
2001)), and was more pronounced for gilts, compared with multiparous sows (Jarvis et al., 476 
2001; Thodberg et al., 2002). The putative pain indicators back leg forward, back arch and 477 
paw began to increase between 3 and 4 hours before the onset of farrowing. This coincides 478 
with a change from nest-building activity to passivity, the increase in myometrial electrical 479 
activity and increasing oxytocin concentrations before the onset of piglet expulsion (Castrén 480 
et al., 1993; Taverne et al., 1979). 481 
 482 
Overall, there were no treatment differences in behavior between ketoprofen and 483 
control treated individuals post-injection. This was similar to previous studies measuring 484 
posture and posture changes in the hours immediately after farrowing in relation to the 485 
administration of analgesics (Haussmann et al., 1999; Mainau et al., 2012; Tenbergen et al., 486 
2014; Viitasaari et al., 2014). This means that it was not possible to validate the putative pain 487 
behaviors as indicators of pain post-farrowing with the use of ketoprofen as an analgesic. 488 
This drug, however, may not have provided adequate analgesia for the pain experienced in 489 
the early post-farrowing period, which is likely to include visceral pain from uterine 490 
contractions moving placental material along the birth canal and uterine involution as the 491 
uterus returns to its normal size, as well as inflammation from the process of parturition 492 
(Deussen et al., 2011). In rodent studies that measured similar putative pain behaviors in the 493 
periparturient period, opioid analgesics reduced the expression of these behaviors, confirming 494 
them as indicators of pain (Catheline et al., 2006; Mirza et al., 2013; Tong et al., 2008), and 495 
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opioid analgesics may be needed to confirm these behaviors as pain indicators in 496 
periparturient sows.  497 
 498 
The earlier administration of an NSAID, during or even before farrowing may 499 
increase the effectiveness, by acting at peripheral and central sites before the onset of 500 
nociceptive input (Ochroch et al., 2003). The use of analgesia administered before surgery 501 
has been shown to reduce post-surgical pain, for example, the use of an NSAID administered 502 
before castration in piglets (e.g. (Keita et al., 2010)). Earlier administration of oral 503 
meloxicam, given as soon as possible at the onset of farrowing, improved piglet outcomes 504 
(growth rate, weaning weight and IgG transfer) (Mainau et al., 2016), compared with studies 505 
in which NSAIDs were given after farrowing (Ison et al., 2017; Mainau et al., 2012; 506 
Viitasaari et al., 2013). This result may also be reflected in indicators of stress and pain in the 507 
sow. However, the administration of NSAIDs before or during farrowing has the potential to 508 
have adverse effects on the sow and piglets. As well as reducing pain and inflammation by 509 
reducing prostaglandin and thromboxane through the inhibition of cyclooxygenase (COX) 510 
enzymes (Hudson et al., 2008), NSAIDs could also inhibit parturition, as prostaglandin 511 
increases towards the onset of farrowing and peaks at the time of birth (Gilbert, 2001). When 512 
the NSAID indomethacin was administered at the onset of nest-building in sows, nest-513 
building behavior was reduced, and parturition tended to be delayed (Gilbert et al., 2002). In 514 
addition, NSAIDs can cross the placenta, which can result in detrimental side effects for the 515 
unborn fetus, where prostaglandins play an important role in developmental and 516 
physiological regulation (Olson, 2005). As discussed, the earlier administration of oral 517 
meloxicam demonstrated enhanced benefits, without detrimental side effects (Mainau et al., 518 
2016). Meloxicam is a selective COX-2 inhibitor (Engelhardt et al., 1995), which could make 519 
it more suitable for the treatment of inflammation (Guerguerian et al., 1998) when given 520 
earlier in the farrowing process than non-selective COX inhibitors, like ketoprofen (Fosse et 521 
al., 2011). Therefore, it cannot be assumed that administering ketoprofen before or during 522 
parturition would have similar benefits to meloxicam. 523 
 524 
Gilts and sows were disturbed around the sampling and piglet processing time, around 525 
7 hours after the injection, showing more posture changes and less putative pain behavior 526 
around this time. This behavior then increased slightly in the remaining post injection 527 
observations. There were large overall differences in the expression of putative pain behavior 528 
between gilts and sows, with gilts showing less back arching and back leg forward behavior 529 
post-injection than sows, and with a different profile of behavioral expression across the 530 
observations. This is a paradoxical result as primiparous dams are generally considered to 531 
experience more pain during the fetal delivery phase of parturition than multiparous dams 532 
(Mainau and Manteca, 2011; Sheiner et al., 1998). In addition, farmers considered pain at 533 
farrowing more often a problem for gilts than sows, and that a greater percentage of gilts than 534 
sows have difficulty farrowing (Ison et al., 2016a). It could be that inexperienced gilts are 535 
more reluctant to show signs of pain or exhibit pain in a different way to more experienced 536 
sows. Alternatively, it is reported in human females that uterine contractions post-birth, 537 
during the process of uterine involution as the uterus contracts and returns to its pre-gestation 538 
size, is more painful for multiparous, compared with primiparous women due to the loss in 539 
uterine tone (Deussen et al., 2011). These after-birth pains are enhanced during breast feeding 540 
as oxytocin is released causing the uterus to contract, and the pain reported by human females 541 
increases with parity, as well as an increase in the frequency and intensity of uterine 542 
contractions recorded using tocodynamometry (Holdcroft et al., 2003). This could explain 543 
why more back arching and back leg forward behavior was seen post-farrowing in sows 544 
compared with gilts, as it is likely that these putative pain indicators are from pain due to 545 
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uterine contraction (Ison et al., 2016b). The authors of the human study suggested  childbirth 546 
could have induced central neural changes that increased the predisposition for pain during 547 
the post-partum period (Holdcroft et al., 2003). Another explanation for the differences in 548 
putative behavioral indicators of pain could be learned pain from previous experiences of 549 
parturition. In humans, fear of pain is thought to contribute to labor-related anxiety, since 550 
anxiety and pain are highly correlated (Lowe, 2002). Excessive anxiety can lead to increased 551 
catecholamine secretion that may enhance nociceptive stimuli from the pelvis and increase 552 
the perception of these stimuli at the cortical level (Lowe, 2002). Pain has been shown to be 553 
under the constant influence of learning processes affecting the anticipation of, and responses 554 
to future pain, as temporary periods of conditioned hyperalgesia were induced by both the 555 
predictability and uncertainty of pain from an electric shock (Taylor et al., 2017). This has 556 
interesting implications for the perception of farrowing pain in primiparous and multiparous 557 
sows. The farrowing environment can be stressful, with different noises, odors and often 558 
includes confinement to a farrowing crate. This could contribute to anxiety due to novelty in 559 
inexperienced gilts, which could enhance the perception of pain, or be associated with a 560 
painful event for experienced sows. Combining an already stressful environment, with fear of 561 
pain for experienced sows could be contributing to an increase in putative behavioral 562 
indicators of pain.         563 
 564 
4.2. Salivary cortisol 565 
 566 
For all gilts and sows, salivary cortisol concentrations increased from 2 days before 567 
farrowing, to 1 day before farrowing and doubled on the day of farrowing. This is similar to 568 
previous studies where salivary (Oliviero et al., 2008) and plasma (Jarvis et al., 1997, 2001; 569 
Lawrence et al., 1994; Molokwu and Wagner, 1973) cortisol were also shown to increase in 570 
the days leading up to and the day of farrowing. In this study, salivary cortisol concentration 571 
remained high up to day 7 post farrowing, which is in contrast to previous studies where 572 
plasma cortisol concentrations returned to pre-farrowing levels 2 days after farrowing in one 573 
study (Molokwu and Wagner, 1973) and another study, but only for sows housed in free-574 
farrowing pens (Oliviero et al., 2008). However, similar to the current study, sows housed in 575 
crates have previously been shown to have elevated salivary cortisol concentrations for at 576 
least the 5 days post farrowing when cortisol was sampled (Oliviero et al., 2008). Therefore, 577 
confining sows to a farrowing crate could be contributing to elevated salivary cortisol during 578 
this time. 579 
 580 
Gilts and sows showed different salivary cortisol profiles; in line with the behavioral 581 
results, sows had higher cortisol on the day of farrowing, but gilts had higher concentrations 582 
on day 3 post farrowing. This is an interesting result as previous research has shown a greater 583 
increase in cortisol in the pre-farrowing nest building phase in crated compared with penned 584 
gilts (Jarvis et al., 1997), but a smaller difference was seen in sows (Jarvis et al., 2001). 585 
Therefore, a greater pre-farrowing and farrowing day cortisol concentration was expected for 586 
the gilts, compared with the sows in this study. However, in the previous studies, samples 587 
were taken in relation to farrowing, whereas in this study, samples were collected at 588 
husbandry times, so may not have picked up the more detailed alterations in cortisol profiles 589 
with nest building and leading up to farrowing. However, it was important to measure 590 
salivary cortisol at the same time each day due to diurnal variations in the concentrations of 591 
this hormone, as well as limit the behavioral disturbance caused by saliva sampling. An 592 
increase in cortisol is not necessarily an indication of psychological stress, it also indicates 593 
the involvement of the metabolic process, including the mobilization of energy to create 594 
homeostasis (Mormède et al., 2007). Nest-building activity, farrowing and the onset of 595 
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lactation is physically demanding, resulting in an increased energy requirement, which could, 596 
in part, explain the increase in salivary cortisol concentrations, especially considering the 597 
feed restrictions imposed on the modern domestic sow. Therefore, the different salivary 598 
cortisol profiles shown by gilts and sows could reflect different metabolic demands 599 
associated with farrowing and lactation between these 2 groups of animals. It should be 600 
noted, however, that a 24 hour feed restriction treatment on grower pigs failed to elicit a 601 
salivary cortisol response (Ott et al., 2014). Therefore, another explanation for the gilt/sow 602 
difference in salivary cortisol could be from individual genetics, as the gilts were obtained 603 
directly from a breeding company, whereas, the sows were home-bred from older genetic 604 
stock. 605 
 606 
Higher concentrations of salivary cortisol on days 1 and 2 post-farrowing was 607 
measured in individuals that required additional treatment compared to healthy animals. It is 608 
possible that as these animals consumed less feed, they may have needed to mobilize energy 609 
reserves and increased cortisol could be an indicator of this. In addition, it could also be that 610 
being unwell is stressful and unpleasant, causing an increased cortisol concentration. In a 611 
study where plasma cortisol was measured in sows experimentally inoculated with 612 
Escherichia coli into the mammary gland on the day of farrowing, 4 out of 12 sows in the 613 
inoculated group developed clinical signs of mastitis (Zhu et al., 2004). All sows showed an 614 
increase in cortisol associated with farrowing, but the 4 sows that developed clinical signs of 615 
mastitis had a greater cortisol increase. Another study showed greater plasma cortisol levels 616 
in sows with mastitis-metritis-agalactia (MMA), compared to healthy sows on days 1, 5, 10, 617 
15 and 20 post-farrowing (Mirko and Bilkei, 2004). In order to better evaluate stress 618 
responses in pigs, measuring a variety of salivary biomarkers is recommended, including 619 
indicators of the sympathetic adrenomedullary system, as well as the hypothalamic–pituitary–620 
adrenocortical axis (Ott et al., 2014).  621 
 622 
4.3. C-reactive protein (CRP) and cytokines 623 
 624 
To minimize disturbance in order to enhance the quality of behavioral data obtained 625 
during this study, only one blood sample was taken for analysis of CRP and cytokines. It 626 
should be noted that one sample, with no baseline, limits the interpretation of the CRP and 627 
cytokine results in this study. In addition, the impact of the blood sampling itself on plasma 628 
concentrations of these biomarkers cannot be discounted, despite efforts to minimize 629 
sampling stress by sampling from the tail vein, not using additional restraint (other than 630 
farrowing crate housing) and using a topical anesthetic. Despite limitations of interpretation, 631 
the results will be discussed in relation to previous studies measuring APPs and pro-632 
inflammatory cytokines in the periparturient period.  633 
 634 
Acute phase proteins (APPs) such as CRP, and pro-inflammatory cytokines are useful 635 
measures of inflammation and tissue damage, used to monitor, detect and diagnose disease 636 
(Petersen et al., 2004). CRP has been identified as a good marker of inflammations in pigs, 637 
increasing 8-fold with experimentally induced sterile inflammation, peaking at 2 days after 638 
the injection of turpentine (Eckersall et al., 1996). Previous studies have shown an increase in 639 
APPs and cytokines in relation to farrowing, regardless of other treatments being studied, 640 
which could be an indication of tissue damage and inflammation associated with the 641 
farrowing process (Sorrells et al., 2007; Szczubiał and Urban-chmiel, 2008; Viitasaari et al., 642 
2013; Zhu et al., 2004). Neither gilt or sow CRP nor the cytokines IL1 β, IL6 or TNF α 643 
differed with ketoprofen treatment, which was similar to a previous study where APPs were 644 
measured in sows in relation to the administration of ketoprofen post farrowing (Viitasaari et 645 
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al., 2013). In this previous study, the APPs haptoglobin (Hp) and serum SAA were measured 646 
on the day before, the days of, then 5 and 14 days post-farrowing, demonstrating that SAA, 647 
but not Hp was elevated in response to farrowing. On day 5, SAA was more elevated in the 648 
ketoprofen treated sows, compared with controls, which the authors suggested could be due 649 
to tissue irritation from the repeated ketoprofen injection (Viitasaari et al., 2013), but no such 650 
result was seen with CRP in the current study. Although CRP was only measured at one time 651 
point in this study, due to high values obtained, in comparison to other studies (Kovác et al., 652 
2008; Oravainen et al., 2006; Sorensen et al., 2006), it is likely that CRP was elevated in 653 
response to parturition, but further samples would need to be taken to confirm this. It is also 654 
worth mentioning that, compared with the current study, 2 previous studies where IL6 and 655 
TNF α were measured using ELISA in parturient sows obtained higher values of TNF α and 656 
lower values of IL6 (Szczubiał and Urban-chmiel, 2008; Zhu et al., 2004) and another study 657 
showed similar values (Papadopoulos et al., 2009).  658 
 659 
Primiparous sows had higher plasma concentrations of CRP than multiparous sows, 660 
and TNF α was greater for sows than gilts. In a previous study, parity influenced serum 661 
concentrations of Hp in that primiparous sows had higher values than multiparous sows 662 
(Verheyen et al., 2007). In contrast to salivary cortisol, no differences in plasma 663 
concentrations of CRP, IL1β, IL6 or TNFα were detected between sows requiring additional 664 
treatment, compared with those that did not. In a study where sows were experimentally 665 
inoculated with intra-mammary E. coli, elevated IL6 and TNF α was measured in inoculated 666 
sows 24 hours post-inoculation, and was greater in sows that developed clinical signs of 667 
mastitis (Zhu et al., 2004). Another study detected a difference in IL6 and TNF α in sows 668 
with MMA, compared with healthy controls at sampling points pre- and post-farrowing, as 669 
well as detecting an increase in these cytokines with parturition (Szczubiał and Urban-chmiel, 670 
2008). It is possible that 6 hours after farrowing may have been too early to detect a 671 
difference, as a previous study detected a difference at 48-72 hours, but not 12-24 hours after 672 
parturition (Szczubiał and Urban-chmiel, 2008) or that the degree of PPDS in the current 673 
study was not severe enough to create an acute phase response. Another study found no 674 
difference in CRP or Hp in sows with vulvar discharge syndrome (VDS), compared with 675 
healthy controls, although severe cases of VDS were not seen (Oravainen et al., 2006). It is 676 
important to note that previous studies involved clinical examinations of sows and confirmed 677 
the involvement of bacterial pathogens, which was not done in this study. 678 
 679 
5. Conclusion 680 
 681 
In line with the previous paper, reporting the production results from the same study, 682 
which did not demonstrate clear benefits to the immediate post-farrowing administration of 683 
ketoprofen (Ison et al., 2017), results of the current study failed to show a change in 684 
indicators of pain, stress and inflammation with the use of post-farrowing ketoprofen. Further 685 
investigation on the timing and types of drug administration, including different regimes for 686 
primiparous and multiparous sows could enable more targeted use of drugs, with potential for 687 
improved sow and piglet outcomes. However, this study did highlight interesting differences 688 
between gilt and sow behavior and physiology, providing a novel insight into the farrowing 689 
experience for naïve and experienced individuals. It is generally thought that the piglet 690 
expulsion phase is likely to be more painful and/or problematic for gilts than sows, whereas 691 
the current study showed that pain in the immediate post-farrowing period could be greater 692 
for sows than gilts. This has implications for the management of farrowing sows, including 693 
the timing, and type of potential management interventions, including closer observation of 694 
experienced sows in the hours post-farrowing.  695 
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Table 1. Ethogram of behaviors observed during the study. Behaviors were recorded as a 947 
duration in seconds (state) or frequencies/counts (event). 948 
 949 
Behavior Description State Event 
P
o
st
u
re
 
Stand Upright, with all feet on floor   
Sit Front legs straight and back end down on the 
floor 
  
Kneel Front knees on the floor, with back legs straight   
Lie lateral Lying on one side with udder exposed   
Lie ventral Lying with the udder on the floor   
S
p
o
n
ta
n
eo
u
s 
b
eh
av
io
rs
 
Tremble Visible shaking as if shivering when in a lateral 
lying position 
 
 
 
Back leg forward In a lateral lying position, the back leg is pulled 
forward and/or in towards the body 
 
 
 
Back Arch In a lateral lying position, one or both sets of 
legs become tense and are pushed away from 
the body and/or inwards towards the center, 
forming an arch in the back 
  
 
Tail flick Tail is moved rapidly up and down   
Paw In a lateral lying position, the front leg is 
scraped in a pawing motion 
  
 
 Piglet birth A piglet is fully expelled from the sow   
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Table 2. Capture and detection antibodies (Ab, with optimised concentrations), recombinant 950 
protein for standards and bead region used for each cytokine (interleukin-1 β (IL1 β), 951 
interleukin-6 (IL6) and tumour necrosis factor α (TNF α)) in the multiplex assay. Adapted 952 
from Hall and Zanella. 953 
Analyte Reagent 
Catalogue # 
 
Description/bead region 
Optimized 
antibody 
concentration 
(µg/ml)/bead 
region 
Source 
IL1β 
Capture Ab 
Detection Ab 
Standard 
Bead 
MAB6811 
BAF681 
681-PI 
MC10029 
Mouse anti-porcine 
Biotinylated goat anti-porcine 
Recombinant Porcine IL-1 β 
Pro Magnetic COOH Beads 29 
20 
0.5 
- 
29 
R&D systems 
R&D systems 
R&D systems 
Bio-Rad 
IL6 
Capture Ab 
Detection Ab 
Standard 
Bead 
AF686 BAF686 
686-PI 
MC10026 
Goat anti-porcine  
Biotinylated goat anti-porcine 
Recombinant Porcine IL-6  
Pro Magnetic COOH Beads 26 
20 
0.5 
- 
26 
R&D systems 
R&D systems 
R&D systems 
Bio-Rad 
TNFα 
Capture Ab 
Detection Ab 
Standard 
Bead 
MAB690 
BAF690 
690-PT 
MC10055 
Mouse anti-porcine 
Biotinylated goat anti-porcine 
Recombinant Porcine  TNF-α 
Pro Magnetic COOH Beads 55 
20 
0.5 
- 
55 
R&D systems 
R&D systems 
R&D systems 
Bio-Rad 
Ab: antibody, Source: R&D Systems, (Abingdon, UK), Bio-Rad, (Hemel Hempstead, UK) 954 
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Table 3. Pre-farrowing a) putative pain behaviors and b) postures and posture changes with 955 
mean ± SEM for gilts and sows, and showing the statistical results for gilt vs. sow, and the 956 
gilt/sow × hour interaction. 957 
 Gilts vs. sow 
Hour pre-
farrowing 
Gilt/sow × 
hour 
a) Putative pain indicators Gilt Sow t, P t, P t, P 
Back leg forward, seconds 46.17 ± 3.61 43.68 ± 2.80 -0.9, 0.4 2.5, 0.01 0.6, 0.6 
Back arch, frequency 0.25 ± 0.03 0.35 ± 0.03 3.5, 0.001 3.6, <0.001 -2.6, 0.009 
Paw, frequency 0.15 ± 0.04 0.18 ± 0.03 0.3, 0.8 4.4, <0.001 0.1, 0.9 
b) Posture Gilt Sow t, P t, P t, P 
Stand, seconds 62.84 ± 4.38 45.39 ± 3.06 -1.7, 0.1 -3.3, 0.001 0.9, 0.4 
Sit, seconds 22.05 ± 2.31 27.20 ± 2.33 0.6, 0.6 -0.7, 0.5 -0.3, 0.7 
Lie lateral, seconds 150.33 ± 5.67 174.11 ± 4.88 2.2, 0.03 -3.3, <0.001 -2.7, 0.008 
Lie ventral, seconds 62.64 ± 4.06 50.48 ± 3.53 1.0, 0.3 -3.4, <0.001 -1.4, 0.1 
Posture changes, frequency 1.44 ± 0.08 1.22 ± 0.07 -3.0, 0.005 7.1, <0.001 2.7, 0.007 
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Table 4. Overall duration or frequencies of putative pain behaviors for 10 15 minute 958 
observations following the injection of a saline control or ketoprofen, with mean ± SEM 959 
displayed by treatment, for gilts and sows and by whether additional treatment was needed, 960 
along with effect size (t) and P values overall and for the interactions with time. 961 
Behavior 
Treatment (treated vs. control) 
Treated/ 
control × time 
treated control t, P t, P 
Back leg forward, seconds 
Tremble, seconds 
Back arch, counts 
177.2 ± 15.0 
116.0 ± 13.7 
  2.5 ± 0.2 
173.5 ± 14.6 
145.8 ± 14.7 
  2.5 ± 0.2 
0.1, 0.9 
-1.6, 0.1 
0.3, 0.8 
-1.0, 0.3 
1.1, 0.3 
0.6, 0.5 
 
Gilt/sow (gilt vs. sow) 
Gilt/sow × 
time 
 gilt sow t, P t, P 
Back leg forward, seconds 
Tremble, seconds 
Back arch, counts 
102.6 ± 13.6 
123.7 ± 13.6 
  1.5 ± 0.1 
233.4 ± 14.6 
137.7 ± 14.6 
  3.3 ± 0.2 
2.3, 0.02 
1.4, 0.2 
3.6, <0.001 
-2.1, 0.04 
-1.3, 0.2 
-2.4, 0.02 
 Additional treatment (yes vs. no) Yes/no × time 
 yes no t, P t, P 
Back leg forward, seconds 
Tremble, seconds 
Back arch, counts 
171.2 ± 21.1 
108.0 ± 20.5 
  2.9 ± 0.3 
176.3 ± 12.0 
137.5 ± 11.6 
  2.4 ± 0.2 
0.8, 0.4 
0.4, 0.7 
0.8, 0.5 
0.1, 0.9 
1.1, 0.3 
-0.5, 0.6 
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Table 5. Mean ± SEM for interleukin-1 β (IL1 β), interleukin-6 (IL6), and tumour necrosis 962 
factor α (TNF α) and c-reactive protein (CRP) in gilt/sow plasma by treatment (control or 963 
treated), by parity group (gilt or sow) and additional treatment (yes or no). Values with 964 
different superscript letters indicate a significant difference (P < 0.05). 965 
Protein 
Treatment Gilt/sow Additional treatment 
Control Treated Gilt Sow Yes No 
IL1β, pg/ml 198.4 ± 37.6 136.8 ± 34.1 187.3 ± 43.5 156.5 ± 31.8 179.1 ± 70.7 165.9 ± 26.7 
IL6, pg/ml 260.9 ± 71.2 251.4 ± 64.0 171.1 ± 33.7 303.9 ± 70.3 136.0 ± 47.7 301.7 ± 61.1 
TNFα, pg/ml 28.1 ± 9.2 24.2 ±8.1 17.8 ± 8.3a 32.0 ± 8.4b 27.4 ± 17.3 25.7 ± 6.3 
CRP, μg/ml 444.0 ± 40.1 489.8 ± 48.6 561.2 ± 36.5a 350.4 ± 36.9b 451.2 ± 58.8 468.3 ± 36.7 
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Figure 1. Mean ± SEM for (A) postures/posture changes; and (B) putative pain behaviors 966 
observed for 5 minutes every hour for the 24 hours before the onset of farrowing.  967 
 968 
 969 
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Figure 2. Mean ± SEM for posture changes, and putative pain behaviors observed for 15 970 
minutes 1, 2.5, 4, 5.5, 7, 8.5, 10, 13, 16 and 19 hours after the ketoprofen or saline injection. 971 
 972 
 973 
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Figure 3. Putative pain behaviors (mean ± SEM) A) Back leg forward; B) Tremble; and C) 974 
Back arch for gilts (in green) and sows (in blue) by hour post injection. 975 
 976 
 977 
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Figure 4. Mean ± SEM of salivary cortisol (ng/ml) by day in relation to farrowing (-2, -1, 0, 1, 2, 3, 5, and 7) for a) all data; b) treatments 978 
(control or treated); c) gilts and sows and; d) additional treatment (no or yes). Days with different letters show a significant difference and bars 979 
with a ** indicates a difference (P < 0.05), and * a tendency (P < 0.1) by day for treatment, gilt/sow or additional treatment. 980 
 981 
